BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38541831)

  • 1. Primary Cutaneous Melanoma-Management in 2024.
    Dixon AJ; Sladden M; Zouboulis CC; Popescu CM; Nirenberg A; Steinman HK; Longo C; Dixon ZL; Thomas JM
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541831
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of invasive melanoma.
    Dixon AJ; Steinman HK; Nirenberg A; Dixon ZL; Anderson S; Dixon JB
    Aust J Gen Pract; 2019 Jun; 48(6):368-372. PubMed ID: 31220882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma.
    Jones S; Henry V; Strong E; Sheriff SA; Wanat K; Kasprzak J; Clark M; Shukla M; Zenga J; Stadler M; Dzwierzynski W; Harker-Murray A; Young K; Kothari AN; Clarke CN
    J Surg Res; 2023 Jun; 286():35-40. PubMed ID: 36739830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update and Review on the Surgical Management of Primary Cutaneous Melanoma.
    Leilabadi SN; Chen A; Tsai S; Soundararajan V; Silberman H; Wong AK
    Healthcare (Basel); 2014 Jun; 2(2):234-49. PubMed ID: 27429273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma.
    Dixon AJ; Kyrgidis A; Sladden M; Nirenberg A; Steinman HK; Smith H; Zachary CB; Anderson S; Leiter-Stöppke U; Longo C; Apalla Z
    J Eur Acad Dermatol Venereol; 2024 Feb; ():. PubMed ID: 38375764
    [No Abstract]   [Full Text] [Related]  

  • 7. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
    Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors.
    de Oliveira Filho RS; de Oliveira DA; Nisimoto MM; Marti LC
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatologic surgeons' approaches to acral lentiginous melanoma: a survey of the American College of Mohs Surgery.
    Isaq NA; Demer AM; Vidal NY; Lohman ME
    Arch Dermatol Res; 2023 Dec; 316(1):17. PubMed ID: 38059993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Controversy and Value of Mohs Micrographic Surgery for Melanoma and Melanoma in Situ on the Trunk and Extremities.
    Zitelli JA; Stiegel E; Brodland DG
    Dermatol Surg; 2023 Dec; 49(12):1061-1065. PubMed ID: 37962134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma.
    Lian B; Li Z; Wu N; Li M; Chen X; Zheng H; Gao M; Wang D; Sheng X; Tian H; Si L; Chi Z; Wang X; Lai Y; Sun T; Zhang Q; Kong Y; Long GV; Guo J; Cui C
    Ann Oncol; 2024 Feb; 35(2):211-220. PubMed ID: 37956739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma.
    Robert C; Carlino MS; McNeil C; Ribas A; Grob JJ; Schachter J; Nyakas M; Kee D; Petrella TM; Blaustein A; Lotem M; Arance A; Daud AI; Hamid O; Larkin J; Anderson J; Krepler C; Grebennik D; Long GV
    J Clin Oncol; 2023 Aug; 41(24):3998-4003. PubMed ID: 37348035
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.